SND1

**SND1** is Shouzu Ning No. 1 formula, an investigational traditional Chinese medicine formula evaluated for treatment of grade 2 vascular endothelial growth factor receptor tyrosine kinase inhibitor-induced hand-foot skin reaction in patients with advanced solid tumors presenting with the traditional Chinese medicine toxic-heat syndrome pattern. A multicenter, randomized, double-blind, placebo-controlled ChiCTR study sponsored by The First Affiliated Hospital of Zhejiang Chinese Medical University was registered in September 2023, but the registry identifies the study as canceled by the investigator. The formula's individual ingredients, dosage form, route, and molecular mechanism were not specified in the public registry record. ([chictr.org.cn](https://www.chictr.org.cn/showproj.html?proj=203565))

Other names

Shouzu Ning No. 1 formula手足宁1号方